Investor Stock List
Ranked #8,233 of 8,699 institutional investors

Velan Capital Investment Management LP

Alpharetta, GA

$81.5M
US stock portfolio at live prices · today −$2.1M (−2.55%)
Live prices, last trade 12:54 PM ET
Value at quarter end (Q3 2026)
$105M
Change from Q2 2026
−$58.6M (−35.90%)
Positions
41 · 6 new, 12 sold out
Filed
Nov 16, 2026

Not counted in the ranking: call options on $130K of stock. $1.3M of holdings we could not match to a US listing are included at their reported quarter-end value.

Holdings

Q3 2026 13F, live prices
PRAX 28.8%IMMX 9.41%TARA 7.92%XNCR 7.17%ABVX 5.97%
StockSharesValue, live% of portfoliovs Q2 2026
PRAX Praxis Precision Medicines, Inc.76,600$23.5M28.8%Reduced −14%
IMMX Immix Biopharma, Inc.1,085,000$7.7M9.41%Unchanged
TARA Protara Therapeutics, Inc.2,844,652$6.5M7.92%Unchanged
XNCR Xencor, Inc.175,000$5.8M7.17%Reduced −31%
ABVX ABIVAX Société Anonyme65,630$4.9M5.97%Unchanged
STRO Sutro Biopharma, Inc.510,038$4.4M5.39%Reduced −0%
MPLT MapLight Therapeutics, Inc.624,703$3.8M4.72%Added +27%
AVR Anteris Technologies Global Corp.700,000$3.5M4.24%Unchanged
EVMN Evommune Inc456,255$3.2M3.95%Added +1%
EDSA Edesa Biotech, Inc.1,282,045$2.7M3.27%Added +55%
HRTX Heron Therapeutics, Inc.8,753,290$2.2M2.75%Unchanged
AVTX Avalo Therapeutics, Inc.324,452$2.2M2.68%Unchanged
EPRX Eupraxia Pharmaceuticals Inc.352,000$2.1M2.54%Unchanged
EWTX Edgewise Therapeutics, Inc.34,250$1.4M1.69%New
QTTB Q32 Bio Inc.120,000$1.0M1.24%New
RNTX Rein Therapeutics Inc.1,700,000$610K0.75%Unchanged
NSPR InspireMD, Inc.924,680$514K0.63%Added +524%
PTGX Protagonist Therapeutics, Inc.3,700$452K0.55%Unchanged
REPL Replimune Group, Inc.20,000$379K0.46%Unchanged
VRDN Viridian Therapeutics, Inc.10,000$305K0.37%Unchanged
DTIL Precision BioSciences, Inc.40,000$290K0.36%Unchanged
OVID Ovid Therapeutics Inc.130,000$285K0.35%Unchanged
CTMX CytomX Therapeutics, Inc.120,000$248K0.30%Unchanged
NRIX Nurix Therapeutics, Inc.16,000$208K0.26%Unchanged
LYEL Lyell Immunopharma, Inc.15,000$203K0.25%Reduced −86%
ANTX AN2 Therapeutics, Inc.40,000$202K0.25%Unchanged
ZLAB Zai Lab Limited9,000$188K0.23%New
CCCC C4 Therapeutics, Inc.70,000$175K0.21%Reduced −88%
IMNM Immunome, Inc.10,000$160K0.20%Unchanged
MLYS Mineralys Therapeutics, Inc.11,000$154K0.19%Unchanged
JBIO Jade Biosciences, Inc.10,000$154K0.19%New
RCKT Rocket Pharmaceuticals, Inc.60,000$120K0.15%Unchanged
MGNX MacroGenics, Inc.60,000$120K0.15%Unchanged
ENTA Enanta Pharmaceuticals, Inc.15,000$116K0.14%New
SCYX SCYNEXIS, Inc.40,000$99K0.12%Unchanged
LRMR Larimar Therapeutics, Inc.33,000$99K0.12%Unchanged
ARTV Artiva Biotherapeutics, Inc.25,000$95K0.12%Unchanged
AARD Aardvark Therapeutics, Inc.85,868$78K<0.1%New
NMRA Neumora Therapeutics, Inc.230,000$72K<0.1%Unchanged
CRBP Corbus Pharmaceuticals Holdings, Inc.30,000$65K<0.1%Added +15%
KLRS Kalaris Therapeutics, Inc.25,000$33K<0.1%Unchanged

Sold out in Q3 2026

StockShares held at Q2 2026Worth today
ADMA ADMA Biologics, Inc.250,000$3.3M
RZLT Rezolute, Inc.750,000$2.9M
VRCA Verrica Pharmaceuticals Inc.471,559$1.3M
PROF Profound Medical Corp.170,278$1.1M
TENX Tenax Therapeutics, Inc.549,985$696K
TECX Tectonic Therapeutic, Inc.6,000$124K
QNRX Quoin Pharmaceuticals, Ltd.32,372$108K
XLO Xilio Therapeutics, Inc.14,285$105K
SNDX Syndax Pharmaceuticals, Inc.10,000$90K
CNTX Context Therapeutics Inc.59,700$10K
GOSS Gossamer Bio, Inc.875$10K
KPTIQ Karyopharm Therapeutics Inc.20,000$640